Femara (letrozole)

October 29, 2018

Therapies Given to Women with Advanced Breast Cancer Equally Effective and Safe in Men, Studies Report

News

Current therapies used to treat advanced breast cancer in women are also effective and safe for men with this disease, according to results of three different studies. These findings were ... Read more

September 22, 2017September 22, 2017

Taselisib-Femara Combo Improves Response in Certain Postmenopausal Women with Early Breast Cancer, Study Shows

News

Adding taselisib to Femara (letrozole) increases the measurable response in certain postmenopausal women with early breast cancer, according to a new study. The benefits were also seen in women whose tumors had ... Read more

April 26, 2017April 26, 2017

Abemaciclib Combo Seen to Slow Progression in Phase 3 Advanced Breast Cancer Trial

News

An interim analysis from the Phase 3 trial known as MONARCH 3 showed that adding abemaciclib to an aromatase inhibitor — Femara (letrozole) or Arimidex (anastrozole) — helped to treat certain postmenopausal women ... Read more

November 28, 2016November 28, 2016

Phase 3 Trial Confirms Ibrance Plus Hormone Therapy Benefits ER+ Breast Cancer Patients

News

The CDK4/6 inhibitor Ibrance (palbociclib), when added to hormone therapy normally given to certain advanced breast cancer patients, considerably benefits these people, researchers at the University of California, Los Angeles (UCLA), reported in an ... Read more

October 12, 2016

Advanced Breast Cancer Outcome Improved with Femara, Ribociclib Combination

News

Combining Norvartis‘ CDK4/6 inhibitor ribociclib with Femara (letrozole) may be a promising first-line therapy for hormone receptor (HR)-positive breast cancer patients, according to recent data from a Phase 3 clinical ... Read more